Atlas Trials

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

Clinical trial NCT05713799 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05713799
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Insulin ResistanceObesity
Start date
2026-08-26
Primary completion
2030-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.